These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31100921)

  • 1. Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors.
    Sato M; Tamura R; Tamura H; Mase T; Kosugi K; Morimoto Y; Yoshida K; Toda M
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31100921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion.
    Tamura R; Ohara K; Morimoto Y; Kosugi K; Oishi Y; Sato M; Yoshida K; Toda M
    Endocr Pathol; 2019 Jun; 30(2):81-89. PubMed ID: 30903445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
    Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
    Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
    Luo M; Tang R; Wang H
    J Neurooncol; 2023 Jul; 163(3):663-674. PubMed ID: 37418134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
    Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
    J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment.
    Wu J; Guo J; Fang Q; Liu Y; Li C; Xie W; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1131693. PubMed ID: 37522128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSPB1 promotes tumor invasion by inducing angiogenesis in PitNETs.
    Li B; Zhao S; Chen Y; Gao H; Xie W; Wang H; Zhao P; Li C; Zhang Y
    Endocr Relat Cancer; 2024 Jun; 31(6):. PubMed ID: 38457246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
    Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
    Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas.
    Cossu G; La Rosa S; Brouland JP; Pitteloud N; Harel E; Santoni F; Brunner M; Daniel RT; Messerer M
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
    Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors.
    Guo X; Yang Y; Qian Z; Chang M; Zhao Y; Ma W; Wang Y; Xing B
    Cancer Lett; 2024 Jun; 592():216908. PubMed ID: 38677640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors.
    Matsuzaki H; Komohara Y; Yano H; Fujiwara Y; Kai K; Yamada R; Yoshii D; Uekawa K; Shinojima N; Mikami Y; Mukasa A
    Microbiol Immunol; 2023 Feb; 67(2):90-98. PubMed ID: 36461910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and vascular characteristics in cavernous sinus meningioma.
    Kosugi K; Tamura R; Ohara K; Morimoto Y; Kuranari Y; Oishi Y; Yoshida K; Toda M
    J Clin Neurosci; 2019 Sep; 67():198-203. PubMed ID: 31213381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.
    Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M
    J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the tumour microenvironment in the angiogenesis of pituitary tumours.
    Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Dorward N; Grieve J; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
    Endocrine; 2020 Dec; 70(3):593-606. PubMed ID: 32946040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
    Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
    Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.
    Bao X; Wang G; Yu S; Sun J; He L; Zhao H; Ma Y; Wang F; Wang X; Wang R; Yu J
    Theranostics; 2021; 11(1):132-146. PubMed ID: 33391466
    [No Abstract]   [Full Text] [Related]  

  • 19. Aggressive nonfunctioning pituitary neuroendocrine tumors.
    Portovedo S; Neto LV; Soares P; Carvalho DP; Takiya CM; Miranda-Alves L
    Brain Tumor Pathol; 2022 Oct; 39(4):183-199. PubMed ID: 35725837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.
    Wen S; Li J; Yang J; Li B; Li N; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():753606. PubMed ID: 34712204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.